Once again, deals and collaborations made news in the biotech sector with BioMarin (BMRN – Analyst Report) announcing its intention to acquire Prosensa (RNA – Snapshot Report) and Five Prime Therapeutics (FPRX – Snapshot Report) signing a second immuno-oncology focused deal with Bristol-Myers Squibb.Meanwhile, AbbVie (ABBV – Analyst Report) continues to progress with its hepatitis C virus (HCV) treatment with […]
Why Has Biogen (BIIB) Stock Been Trading Down?
Biogen stock has been falling due to patent issues and negative sentiments regarding the death of a patient who had been using Tecfidera. However, the company’s pipeline drugs show potential
Published: November 21, 2014 at 2:19 pm ESTBy: Hannah IshmaelPage 1 of 2
Click Ticker to See live coverageBIIB
FWP
NVS
Biogen Idec Inc (NASDAQ:BIIB) stock has been […]
Friday was a choppy session with little momentum as indexes have now worked off their extreme overbought conditions. The S&P 500 added 0.02% and the NASDAQ 0.18%. U.S. retail sales rose 0.5% last month when stripping out volatile elements like gasoline, autos, building materials and food services, according to the Commerce Department data released on Friday. That was the biggest […]
It was all about earnings last week with several biotech companies reporting third quarter results. While it was a “beat and raise” quarter for quite a few companies, some companies narrowed their outlooks for the year.Recap of the Week’s Most Important Stories1. Companies like Celgene (CELG – Analyst Report), Biogen (BIIB – Analyst Report), Alexion (ALXN – Analyst Report), Cubist […]
